This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Apr. 12, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!



Intense pain may be all in your genes
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Why do some people feel pain more than others? Scientists discovered a major gene that could help answer the question and could someday lead to new ways to treat chronic pain, according to a study published in Nature Medicine. Pain and pain-reducing drugs evoke widely varying responses in people, but little is known about the genetics of pain sensitivity, scientists said. More

Study: Rare-gene children at risk with post-surgery codeine
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Concerns about codeine safety have gained traction in the wake of the postoperative experience of four children who all carried a rare genetic mutation. A new study describes what happened to three of the patients, while a similar case came to light in 2009. In certain, very rare genetic cases, the common painkiller codeine can be lethal. More

Is niceness in our genes?
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Niceness may be predicted, in part, by our genes, a new study suggests. Researchers found that actual niceness — defined as feelings of social responsibility and charity — corresponded with possessing a gene that produced a certain kind of receptor for oxytocin and vasopressin — two hormones linked with sociability and niceness. More

 Biotech/Diagnostics/Personalized Medicine

Gene discovery may progress personalized stomach cancer treatment
HealthDay News via MSN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An international team of researchers has identified hundreds of new genes that are mutated in stomach cancer, in a finding they say could lead to treatments tailored to the genetic make-up of individual stomach tumors. Stomach cancer treatment is often difficult and unsuccessful. In the United States, less than one-quarter of stomach cancer patients survive more than five years after diagnosis. More

Prostate-test fees challenged
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Doctors in urology groups that profit from tests for prostate cancer order more of them than doctors who send samples to independent laboratories, according to a Health Affairs study. The study found doctors' practices that do their own lab work bill the federal Medicare program for analyzing 72 percent more prostate tissue samples per biopsy while detecting fewer cases of cancer than counterparts who send specimens to outside labs. More

Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

Stem cell researchers closer to drug to control cystic fibrosis
Journal Sentinel    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefHarvard University stem cell researchers believe they have taken an important step toward development of a drug to control cystic fibrosis. The advance, described in the journal Cell Stem Cell, involves the technique of growing cells from humans with a disease in order to test compounds against the ailment. More

Texas accused of ignoring FDA on stem cell rules
Houston Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Texas' proposed adult stem cell regulations, up for approval, are under fire for circumventing the Food and Drug Administration and making the experimental therapy commercially available before it's been proven safe and effective. The criticism of the Texas Medical Board draft policy is coming from a host of pre-eminent scientists and institutions, including the influential scientific journal Nature and the International Society for Stem Cell Research. More

 Emerging Medical Technologies

Can autism really be diagnosed in minutes?
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Autism is an extremely complex diagnosis. Parental insight, physician observations and hours of data can factor into determining whether a child actually is autistic. Now a Harvard researcher has published research about a Web-based tool he developed that promises to diagnose autism in minutes, a proposition that has some autism experts so skeptical they're not even willing to speak on the record about it. More

Surgeon leads way for magnet heartburn treatment
KNSD-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A string of magnets could mean the answer to those who suffer from heartburn and haven't found relief with diet or lifestyle changes. Doctors at the University of California, San Diego have placed a LINX device into a patient — the first surgery of its kind since the FDA approved the string of titanium beads that create a loop or ring shape to treat chronic heartburn. More

 Managed Healthcare News

Most insurance covers little of cost of hearing aids
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Only a quarter of the 35 million U.S. adults who could benefit from hearing aids actually get them, and one of the main reasons is money. A hearing aid typically costs a few thousand dollars, sometimes much more, and most insurance plans don't cover that. Medicare generally doesn't pay anything, though hearing loss is a common concern among its beneficiaries. More

Has saturation point for under-26 coverage been reached?
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Has one of the health law's most popular benefits – the provision that allows children to stay on their parents' insurance up to age 26 — hit a plateau? A recent survey suggests this might be case. According to a recent Gallup poll, the uninsured rate among 18- to 25-year-olds has leveled off around 24 percent since early 2011. More

 FDA: New Treatments and Technology

FDA adds blood clot risk information to birth control pills
The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Federal health regulators said Tuesday they are adding labeling to Yaz and other newer birth control pills emphasizing that the drugs may be more likely to cause blood clots than older contraceptive pills. More

Hospital scramble on front lines of drug shortages
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Shortages of prescription drugs have been a growing concern for the past six years. The Food and Drug Administration has been scrambling to respond. Shortfalls are so common that pharmacy staffers at hospitals are spending many extra hours to ensure an uninterrupted flow of medicine to cancer patients, victims of heart attacks and accidents and a host of other ill people. More

"People of all ages can suffer from gastroesophageal reflux disease, which causes heartburn. You can have GERD without heartburn, but it is the most common symptom, according to the National Institute of Diabetes and Digestive and Kidney Diseases."
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 5, 2012
March 29, 2012
March 22, 2012
March 15, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063